BDBM50334039 (S)-3-methyl-4-(3-(4-(3-(trifluoromethyl)phenyl)-1H-imidazol-2-yl)benzyl)morpholine::CHEMBL1644678

SMILES C[C@H]1COCCN1Cc1cccc(-c2nc(-c3cccc(C(F)(F)F)c3)c[nH]2)c1

InChI Key InChIKey=HWCMNGZGIQKDGG-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 50334039   

TargetCannabinoid receptor 2(Human)
Merck Research Laboratory

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50334039BDBM50334039((S)-3-methyl-4-(3-(4-(3-(trifluoromethyl)phenyl)-1...)
Affinity DataEC50:  169nMAssay Description:Agonist activity at human cloned CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2011
Entry Details Article
PubMed